Scholarlink

<p>Genetic surveillance of <i>Plasmodium falciparum</i> (<i>Pf</i>) can track antimalarial-resistant strains, to inform decision-making by National Malaria Control Programmes (NMCPs). The GenRe-Mekong project prospectively collected 5982 samples in the Greater Mekong Subregion (GMS) between 2017 and 2022, genotyping drug resistance markers, and barcodes that recapitulate genetic variation. Genotypes were analyzed with the grcMalaria R package, first described in this paper, to translate genetic epidemiology data into actionable visual information. Since 2020, <i>Pf</i> incidences decreased rapidly, accompanied by a decline of dihydroartemisinin-piperaquine (DHA-PPQ) resistant lineages, previously dominant in the eastern GMS. The frequency of <i>plasmepsin2/3</i> amplifications, conferring piperaquine resistance, dropped from 62% in 2017-2019 to 2% in 2022, coinciding with a switch in frontline therapy in Cambodia, Thailand, and Vietnam. While regional artemisinin resistance levels remained high, no evidence of emerging mefloquine resistance was found. Routine genetic surveillance proved valuable in monitoring rapid parasite population changes in response to public health interventions, providing actionable information for NMCPs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月20日

查看全文
  • Varanya Wasakul,
  • Tess D. Verschuuren,
  • Nguyen Thuy-Nhien,
  • Ethan Booth,
  • Huynh Hong Quang,
  • Ngo Duc Thang,
  • Keobouphaphone Chindavongsa,
  • Siv Sovannaroth,
  • Virasak Banouvong,
  • Viengphone Sengsavath,
  • Mayfong Mayxay,
  • Nguyen Thi Kim Tuyen,
  • Vo Ngoc Lam Phuong,
  • Pham Duc Trung,
  • Sónia Gonçalves,
  • Soun Chen,
  • Sonexay Phalivong,
  • Saiamphone Xayvanghang,
  • Supaporn Mahaphontrakoon,
  • Richard D. Pearson,
  • Paul N. Newton,
  • Richard J. Maude,
  • Elizabeth A. Ashley,
  • Cristina V. Ariani,
  • Victoria J. Simpson,
  • Nicholas P. Day,
  • Arjen M. Dondorp,
  • Olivo Miotto

摘要

Genetic surveillance of Plasmodium falciparum (Pf) can track antimalarial-resistant strains, to inform decision-making by National Malaria Control Programmes (NMCPs). The GenRe-Mekong project prospectively collected 5982 samples in the Greater Mekong Subregion (GMS) between 2017 and 2022, genotyping drug resistance markers, and barcodes that recapitulate genetic variation. Genotypes were analyzed with the grcMalaria R package, first described in this paper, to translate genetic epidemiology data into actionable visual information. Since 2020, Pf incidences decreased rapidly, accompanied by a decline of dihydroartemisinin-piperaquine (DHA-PPQ) resistant lineages, previously dominant in the eastern GMS. The frequency of plasmepsin2/3 amplifications, conferring piperaquine resistance, dropped from 62% in 2017-2019 to 2% in 2022, coinciding with a switch in frontline therapy in Cambodia, Thailand, and Vietnam. While regional artemisinin resistance levels remained high, no evidence of emerging mefloquine resistance was found. Routine genetic surveillance proved valuable in monitoring rapid parasite population changes in response to public health interventions, providing actionable information for NMCPs.